[Pharmacogenetic-assisted drug development. Regulatory aspects from the viewpoint of the Medical Products Agency].
Theilade
Mette Due
MD
mdt@dkma.dk
D000818:Animals; D002986:Clinical Trials as Topic; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics; D003718:Denmark; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D005060:Europe; D017408:Guidelines as Topic; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D013678:Technology, Pharmaceutical
D003577:Cytochrome P-450 Enzyme System